March 6, 2019
The Ministry of Health, Labor and Welfare (MHLW) on March 4 granted orphan designation to six compounds including Takeda Pharmaceutical’s cancer drug Adcetris (brentuximab vedotin) for the treatment of CD30-positive peripheral T-cell lymphoma. The five other compounds are: 1) Kyowa...read more